TheraRadar
← Back
Data updated: Jun 28, 2026

MARSAM PHARMS LLC

Generics

MARSAM PHARMS LLC is a generic drug manufacturer focused on Cardiovascular, Dermatology.

1987
Since
13
Drugs
-
Trials
1
New Drugs (2yr)

MARSAM PHARMS LLC's Key Drugs

MARSAM PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

MARSAM PHARMS LLC's Therapeutic Areas

MARSAM PHARMS LLC's approved drugs and pipeline span 2 therapeutic areas, led by Cardiovascular and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Cardiovascular 50%
1 drugs
Dermatology 50%
1 drugs

MARSAM PHARMS LLC's Top Competitors

MARSAM PHARMS LLC's closest competitors by therapeutic-area and drug-target overlap include Baxter, Bayer, and B BRAUN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

MARSAM PHARMS LLC Pipeline Snapshot

Active clinical trials for MARSAM PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Cardiovascular pipeline focus
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling